Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk
Tags stocks S&P 500 Investing
From CNBC.com News
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
Tags Goodrx Holdings Inc Progyny Inc AI / Artificial Intelligence
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Business US: News Health care policy
From CNBC.com News
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
Tags Inflation Markets Novo Nordisk A/S
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Biotech and Pharmaceuticals Science Health & Science
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Biotech and Pharmaceuticals Pharmaceuticals Biotechnology
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Health & Science Biotech and Pharmaceuticals AstraZeneca PLC
From CNBC.com News
Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
Tags Europe Markets Dassault Systemes SE Markets
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Health care industry Novo Nordisk A/S Health & Science
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Biotech and Pharmaceuticals Health & Science Novo Nordisk A/S
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Business US: News Companies
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Crime Health & Science Prescription drugs
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Amgen Inc Social issues Healthy Returns
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Biotechnology Novo Nordisk A/S Health care industry
From CNBC.com News
Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
Tags Wall Street Exchange/traded funds NVIDIA Corp
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Companies US: News Business
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Technology Investment strategy Economy
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Pharmaceuticals Health care industry Biotechnology
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Business News LILLY DRN Health care industry
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags Social issues Healthy Returns Viking Therapeutics Inc
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Healthy Returns Social issues UnitedHealth Group Inc
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags Biotech and Pharmaceuticals Health & Science Breaking news
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Business US: News Companies
From CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Tickers HIMS LLY NEWS NVO
Tags Benzinga LLY HIMS
From Benzinga
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Health care industry Novo Nordisk A/S Amazon/com Inc
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Tags Companies US: News Business
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Abbott Laboratories Social issues LILLY DRN
From CNBC.com News
Cramer's Lightning Round: Uranium Energy is 'the real deal'
Tags Mad Money Investment strategy Stock markets
From CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags LILLY DRN Zealand Pharma A/S Europe News
From CNBC.com News
Ozempic underworld: Inside the black market of obesity drugs
Tags Health care industry Novo Nordisk A/S World News
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.